Balchem price target lowered to $180 from $190 at H.C. Wainwright

H.C. Wainwright analyst Raghuram Selvaraju lowered the firm’s price target on Balchem (BCPC) to $180 from $190 and keeps a Buy rating on the shares following the Q1 repot. The company’s base business appears relatively resistant to macro pressures, the analyst tells investors in a research note.